Apogent again extends consent deadline for 6½% notes, coincides with tender expiration

New York, June 18 - Apogent Technologies Inc. (Ba2/BB+) said it has again extended the pending solicitation of noteholder consents to changes in the indenture of its 6½% senior subordinated notes due 2013, which it undertook as part of its previously announced tender offer for those notes.

Apogent said that the consent deadline has now been extended to 5 p.m. ET on July 1 - coinciding with the expiration of the underlying tender offer - subject to possible further extension from the previous deadline at 5 p.m. ET on June 17.

It said that all tendering holders would now receive the previously announced total consideration.

As previously announced, Apogent Technologies, a Portsmouth, N.H.-based laboratory and life sciences products company, said on May 28 that it had begun a cash tender offer for all its $250 million principal amount of the 6½% notes and was also soliciting consents to amend the notes to eliminate substantially all of the restrictive covenants.

The company set a June 11 consent deadline, which was later extended, and said that the offer would expire at 5 p.m. ET on July 1, subject to possible extension.

It initially said it would offer 101.75% of par for holders tendering by the consent deadline, and 101% of par for holders tendering after that point but before the July 1 expiration date, but subsequently extended the consent deadline to coincide with the expiration. All tendering holders would also receive accrued interest up to but not including the settlement date.

The company said holders could not consent to the amendments without also tendering their notes and could not revoke their consents without also withdrawing the previously tendered notes.

It further said that the tender offer and consent solicitation would be conditioned upon the completion of the proposed merger between Apogent and Fisher Scientific International Inc. and the receipt of the required consents in the consent solicitation.

Goldman, Sachs & Co. is the dealer manager and solicitation agent (800 828-3182). Innisfree M&A Inc. is the information agent (888 750-5834).

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.